Related Experiment Video
Updated: Jun 3, 2026

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
Published on: September 25, 2017
Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study
S Bo1, C Mandrile, N Milanesio
1Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. sbo@molinette.piemonte.it
Insights
Left ventricular hypertrophy (LVH) is linked to systemic inflammation. This study shows baseline LVH predicts higher C-reactive protein (CRP) levels at follow-up, independent of other risk factors.
Area of Science:
- Cardiology
- Inflammation Research
- Biomarkers
Background:
- Conflicting evidence exists on the association between sub-clinical inflammation and left ventricular hypertrophy (LVH).
- Investigating the link between baseline LVH and high-sensitivity C-reactive protein (CRP) is crucial for understanding cardiovascular health.
- Previous cross-sectional studies suggest a connection, but longitudinal data is needed.
Purpose of the Study:
- To examine the association between baseline left ventricular hypertrophy (LVH) and high-sensitivity C-reactive protein (CRP) levels.
- To determine if baseline LVH predicts future CRP levels in a population-based cohort.
- To assess this association in both a general population and a healthier subgroup, excluding common confounding factors.
Main Methods:
- A population-based cohort (n=1564) and a healthier subgroup (n=515) were analyzed.
- Left ventricular hypertrophy (LVH) was assessed using ECG criteria (Cornell voltage-duration product).
- High-sensitivity C-reactive protein (CRP) levels were measured at baseline and after a six-year follow-up, with adjustments for confounders.
Main Results:
- 10.6% of subjects exhibited baseline left ventricular hypertrophy (LVH).
- Individuals with LVH had higher BMI, waist circumference, blood pressure, and CRP levels at baseline and follow-up.
- Baseline LVH independently predicted higher CRP levels at follow-up in multivariable regression models.
Conclusions:
- Baseline left ventricular hypertrophy (LVH) is associated with systemic inflammation.
- LVH predicts elevated C-reactive protein (CRP) levels at follow-up, independent of cardiovascular and metabolic risk factors.
- The inflammatory pathways linked to LVH warrant further investigation.
Background And Aims:
Cross-sectional studies have shown that chronic sub-clinical inflammation is associated with left ventricular hypertrophy (LVH), but results are conflicting. We investigated the association between baseline LVH and high-sensitivity C-reactive protein (CRP) values, both cross-sectionally and after a six-year-follow-up, in a population-based cohort (n = 1564) and a subgroup from this cohort (n = 515), without obesity, diabetes, metabolic syndrome or any drugs.
Methods And Results:
ECG tracings at baseline were interpreted according to the Cornell voltage-duration product criteria: 166/1564 subjects (10.6%) showed LVH. Patients with baseline LVH showed increased BMI, waist circumference, blood pressure, and a worse metabolic pattern. Their CRP values both at baseline and at follow-up were almost two-fold higher than in patients without LVH. Similar results were found in the healthier sub-sample. In a multiple regression model, CRP at follow-up was directly associated with baseline LVH (expressed as Cornell voltage-duration product) in the whole cohort (β = 0.0003; 95%CI 0.0002-0.0006; p < 0.001) and in the sub-sample (β = 0.0003; 0.0002-0.0004; p < 0.001), after adjusting for age, sex, BMI, waist circumference, smoking, exercise levels, blood pressure and baseline CRP values.
Conclusion:
Baseline LVH, which is associated with systemic inflammation, predicts increased CRP values at follow-up, independently of cardiovascular and metabolic risk factors, both in a population-based cohort and a healthier sub-sample. The inflammatory consequences of LVH might be an intriguing subject for further researches.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Chronic Inflammation: Introduction

